NCT01412346

Brief Summary

The purpose of this study is to investigate the effects of a Nordic diet rich in plant-based foods and fish on indicators of cardiovascular disease risk at two different levels of salt intake. The study is a 20-wk randomized controlled crossover trial. The subjects follow a salt-restricted diet during the study. The study begins with a 4-wk run-in phase for all subjects. After that the subjects are randomly allocated to one of two groups. Group 1 consumes a healthy Nordic low-salt diet enriched with plant-based foods and fish for 16 weeks. Group 2 consumes a low-salt diet for 16 weeks. During the 16 weeks, both groups receive salt and placebo capsules in a double-blind, crossover fashion (8+8 weeks).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
111

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 9, 2011

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

October 15, 2014

Status Verified

October 1, 2014

Enrollment Period

1.4 years

First QC Date

August 3, 2011

Last Update Submit

October 13, 2014

Conditions

Keywords

humanclinical trialdietary intervention studyblood pressurecardiovascular biomarkersnutritional biomarkersgene expression

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in systolic and diastolic blood pressure after treatments

    12 and 20 weeks

Secondary Outcomes (4)

  • Change from baseline in PFA-100 measurements after treatments

    12 and 20 weeks

  • Change from baseline in biomarkers of cardiovascular disease risk after treatments

    12 and 20 weeks

  • Change from baseline in nutritional biomarkers after treatments

    12 and 20 weeks

  • Change from baseline in blood cell gene expression after treatments

    12 and 20 weeks

Study Arms (2)

Plant-based food and fish with salt restr.

ACTIVE COMPARATOR

The subjects consume plant based foods (fruits, berries, vegetables, whole grain) and fish in addition to a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design).

Other: Effects of a Nordic diet rich in plant-based foods and fish

Diet with salt restriction

PLACEBO COMPARATOR

The subjects follow a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design).

Other: Effects of a Nordic diet rich in plant-based foods and fish

Interventions

The intervention lasts for 20 weeks and it includes dietary counseling concerning salt restriction. Key foods are provided to the subjects.

Diet with salt restrictionPlant-based food and fish with salt restr.

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • prehypertension or hypertension (systolic blood pressure 130-159 mmHg or diastolic blood pressure 85-99 mmHg)

You may not qualify if:

  • smoking
  • regular use of medications
  • intestinal disorders
  • symptomatic cardiovascular disease
  • obesity (BMI\>35 kg/m2)
  • vegetarianism
  • high intake of alcohol
  • allergy to fish
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute for Health and Welfare

Helsinki, FI-00271, Finland

Location

Related Publications (1)

  • Niiranen T, Erlund I, Jalkanen S, Jula A, Salmi M. Effects of altered salt intake and diet on cytokines in humans: A 20-week randomized cross-over intervention study. Eur J Immunol. 2023 Jan;53(1):e2250074. doi: 10.1002/eji.202250074. Epub 2022 Nov 20.

MeSH Terms

Conditions

PrehypertensionHypertension

Interventions

In Situ Hybridization, Fluorescence

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

In Situ HybridizationStaining and LabelingHistocytological Preparation TechniquesCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHistological TechniquesInvestigative TechniquesCytogenetic AnalysisGenetic TechniquesNucleic Acid Hybridization

Study Officials

  • Iris Erlund, Dr.

    Finnish Institute for Health and Welfare

    STUDY DIRECTOR
  • Antti Jula, Dr.

    Finnish Institute for Health and Welfare

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD., senior researcher

Study Record Dates

First Submitted

August 3, 2011

First Posted

August 9, 2011

Study Start

January 1, 2011

Primary Completion

June 1, 2012

Study Completion

September 1, 2014

Last Updated

October 15, 2014

Record last verified: 2014-10

Locations